AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript February 20, 2024 AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. […]
MIL-OSI: Acceleware Awarded $3 Million in Non-Dilutive Funding from The Clean Resource Innovation Network foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
Additional Funding for RF XL Commercial-Scale PilotCALGARY, Alberta, Nov. 06, 2023 Acceleware Ltd. , a leading innovator of transformative technologies targeting the decarbonization of.